The primary genetic alterations, known to consistently be associated with this group of tumors, include alterations in the receptor-associated tyrosine kinases for FGFR3, HRAS, KDM6A, KMT2D, and PIK3CA. Chromosome 9 deletion occurs in the early phase of BC tumorigenesis. The gene discussed is FGFR3; the disease is breast cancer.